BioSpace News Archive

vector liver on top of a pedestal on a white background

Gene therapy

Analysts Brush Off Intellia’s Adverse Event but Gene Therapy Safety Concerns Continue

While an adverse event reported in Intellia’s gene therapy trial was a “non-concern” for analysts, it follows a handful of patient deaths in other trials for the modality and sent the company’s stock tumbling in pre-market trading.

May 29, 2025

·

3 min read

·

Annalee Armstrong

Illustration showing American flag with half-open door on the side

Job Trends

Sounding Off: Political Climate, Job Market Have Some Eyeing Biopharma Work Abroad

Nearly a third of employed and almost half of unemployed BioSpace survey respondents are seriously considering leaving the U.S. to find biotech and pharma jobs. Concerns about how the political climate is affecting biopharma are a key driver for many.

May 29, 2025

·

5 min read

·

Angela Gabriel

Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.

Company closure

iTeos To Close Down After TIGIT Fail

iTeos expects to absorb nearly $25 million in one-time costs for severance and termination payments. The biotech had 173 full-time employees at the end of 2024.

May 29, 2025

·

2 min read

·

Tristan Manalac

Press Releases

Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology

May 29, 2025

·

4 min read

Press Releases

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy